Search
Cilastatin
go.drugbank.com/drugs/DB01597ApprovedInvestigationalCilastatin is an inhibitor of renal dehydropeptidase, an enzyme responsible for both the metabolism of thienamycin beta-lactam antibiotics as well as conversion of leukotriene D4 to leukotriene E4. … The first combination product containing both drugs was approved by the FDA in November of 1985 under the trade name Primaxin, marketed by Merck & Co.
Mixtures: IMIPENEM E CILASTATINA SUN, IMIPENEM E CILASTATINA SUNProducts: IMCIL POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/500MG PER VIALBenzoyl peroxide
go.drugbank.com/drugs/DB09096ApprovedInvestigational[L33249,L33264,L33269,L33299,L33314] It has been formulated as products with either a single active ingredient,[L33249,L33299] or with [erythromycin],[L33264] [clindamycin],[L33269] or [adapalene]. … [A18903,A233859] This treatment decreases keratin and sebum around follicles, as well as increasing turnover of epithelial cells.
Mixtures: OXIMIN 10 MG/G + 50 MG/G JEL,50 G, OXIMIN 10 MG/G + 50 MG/G JEL,25 GProducts: Clinique Acne Solutions All-over Clearing Treatment, OXY COVER CREAMChlorine dioxide
go.drugbank.com/drugs/DB12453ApprovedChlorine Dioxide has been used in trials studying the treatment of Halitosis.
Categories: Compounds used in a research, industrial, or household settingProducts: Pure O2 S, Pure O2-S FAluminum zirconium pentachlorohydrate
go.drugbank.com/drugs/DB11147ApprovedIts main mechanism of action is through blocking the pores via formation of polymer complex and preventing sweat from leaving the body.
Products: On Duty 24 Hours Clear Protection Roll-On Anti-Perspirant DeodorantTrabectedin
go.drugbank.com/drugs/DB05109ApprovedInvestigationalOn October 23, 2015, the FDA approved trabectedin, (as Yondelis), for the treatment of specific soft tissue sarcomas. … Trabectedin has a unique mechanism of action. It binds to the minor groove of DNA interfering with cell division and genetic transcription processes and DNA repair machinery.
Products: TRABECTEDINA SUN, Trabectedin SUN 1 mg Pulver für ein Konzentrat zur Herstellung einer InfusionslösungSNS-314
go.drugbank.com/drugs/DB06134InvestigationalSNS-314 is a potent and selective inhibitor of Aurora kinases A, B, and C. … SNS-314 inhibits tumor growth in a variety of preclinical models, and it is now being tested in single agent Phase 1 studies in patients with advanced solid tumours.
Salts: SNS-314 mesylateTemozolomide
go.drugbank.com/drugs/DB00853ApprovedInvestigationalconsiderable genetic heterogeneity, these tumours often have impaired DNA repair systems, rendering them initially sensitive to alkylating agents, although they invariably develop resistance to these agents over … [L32033] Temozolomide was granted FDA approval on August 11, 1999, as an oral capsule and subsequently on February 27, 2009, as an intravenous injection.
Products: TEMOZOLOMIDE SUN, Temozolomide SunStearic acid
go.drugbank.com/drugs/DB03193ApprovedStearic acid (IUPAC systematic name: octadecanoic acid) is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is a waxy solid.
Mixtures: O Hui Veil Fit Dual Foundation 20, O Hui Veil Fit Dual Foundation 30Products: K Oxiderm Op, K Oxiderm OP Post Procedure skin care bruiseTechnetium Tc-99m disofenin
go.drugbank.com/drugs/DB09164ApprovedWithdrawnIt is well suited for both planar and single photon tomographic scintigraphy to quantitatively measure the function of liver, gallbladder and bile ducts and detect any anatomical changes in the hepatobliary … However disofenin is the most commonly used iminodiacetic acid since it has a high liver to renal extraction and its hepatic uptake is not as highly dependent on serum bilirubin levels (a competitive inhibitor
Categories: Diagnostic Uses of Chemicals, Compounds used in a research, industrial, or household settingProducts: Kit for the Preparation of Technetium Tc99m Disofenin1,2-icosapentoyl-sn-glycero-3-phosphoserine
go.drugbank.com/drugs/DB14096ApprovedSalts: 1,2-icosapentoyl-sn-glycero-3-phosphoserine calciumSynonyms: 1,2-icosapentoyl-sn-glycero-3-phosphoserine